logo-loader

Akari Therapeutics

Receive alerts
Market:
NASDAQ
Market Cap:
$41.6 m
Price
1.98 USD
Change
0.00%
52 weeks high
9.19
52 weeks low
1.56

In brief

We are developing life-transforming treatments for autoinflammatory diseases involving the complement (C5) and leukotriene (LTB4) pathways.